Daniel W. Cramer

35.6k total citations · 3 hit papers
244 papers, 13.6k citations indexed

About

Daniel W. Cramer is a scholar working on Reproductive Medicine, Genetics and Obstetrics and Gynecology. According to data from OpenAlex, Daniel W. Cramer has authored 244 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Reproductive Medicine, 42 papers in Genetics and 41 papers in Obstetrics and Gynecology. Recurrent topics in Daniel W. Cramer's work include Ovarian cancer diagnosis and treatment (75 papers), Ovarian function and disorders (40 papers) and Endometriosis Research and Treatment (29 papers). Daniel W. Cramer is often cited by papers focused on Ovarian cancer diagnosis and treatment (75 papers), Ovarian function and disorders (40 papers) and Endometriosis Research and Treatment (29 papers). Daniel W. Cramer collaborates with scholars based in United States, United Kingdom and Australia. Daniel W. Cramer's co-authors include Stacey A. Missmer, William R. Welch, Bernard L. Harlow, Allison F. Vitonis, Linda Titus‐Ernstoff, Huijuan Xu, Marlene Goldman, Kathryn L. Terry, Francine Grodstein and Ross S. Berkowitz and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Daniel W. Cramer

241 papers receiving 13.0k citations

Hit Papers

The Tubal Fimbria Is a Preferred Site f... 1983 2026 1997 2011 2006 1983 1983 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel W. Cramer United States 65 6.6k 3.1k 2.9k 2.4k 2.1k 244 13.6k
Susanne K. Kjær Denmark 72 3.5k 0.5× 2.5k 0.8× 2.0k 0.7× 3.9k 1.6× 1.5k 0.7× 625 22.8k
Nobuo Yaegashi Japan 53 4.4k 0.7× 4.4k 1.4× 1.9k 0.7× 3.5k 1.5× 1.9k 0.9× 648 14.2k
Matthias W. Beckmann Germany 60 2.6k 0.4× 2.6k 0.8× 2.8k 1.0× 3.6k 1.5× 1.4k 0.7× 654 15.3k
Yutaka Osuga Japan 57 6.8k 1.0× 5.5k 1.8× 2.6k 0.9× 2.2k 0.9× 941 0.5× 573 13.5k
Ulf‐Håkan Stenman Finland 70 2.6k 0.4× 1.4k 0.5× 2.5k 0.9× 5.5k 2.3× 1.2k 0.6× 608 20.1k
Hys Ngan Hong Kong 68 4.1k 0.6× 4.3k 1.4× 2.6k 0.9× 6.9k 2.9× 1.3k 0.6× 521 21.5k
Clemens Tempfer Austria 52 2.6k 0.4× 1.9k 0.6× 930 0.3× 1.9k 0.8× 796 0.4× 374 9.2k
Jonathan S. Berek United States 67 8.1k 1.2× 7.4k 2.4× 910 0.3× 1.9k 0.8× 1.2k 0.6× 297 16.6k
Cindy Farquhar New Zealand 73 11.6k 1.8× 6.4k 2.1× 7.5k 2.6× 955 0.4× 1.5k 0.7× 330 18.6k
John A. Collins Canada 53 5.6k 0.8× 1.2k 0.4× 3.1k 1.1× 1.5k 0.7× 810 0.4× 221 11.5k

Countries citing papers authored by Daniel W. Cramer

Since Specialization
Citations

This map shows the geographic impact of Daniel W. Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Cramer more than expected).

Fields of papers citing papers by Daniel W. Cramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Cramer. The network helps show where Daniel W. Cramer may publish in the future.

Co-authorship network of co-authors of Daniel W. Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel W. Cramer. A scholar is included among the top collaborators of Daniel W. Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel W. Cramer. Daniel W. Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al-Alem, Linah, Jillian M. Prendergast, Justin Clark, et al.. (2024). Sialyl-Tn serves as a potential therapeutic target for ovarian cancer. Journal of Ovarian Research. 17(1). 71–71. 9 indexed citations
2.
Cramer, Daniel W., Allison F. Vitonis, Tianyi Huang, et al.. (2023). Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels. Cancer Epidemiology Biomarkers & Prevention. 32(7). 976–985. 1 indexed citations
3.
Barnes–Josiah, Debora, et al.. (2022). Factors Influencing the Results of COVID-19 Case Outreach—Results From a California Case Investigation/Contact Tracing Program. Journal of Public Health Management and Practice. 28(6). 639–649. 2 indexed citations
4.
Sasamoto, Naoko, Ana Babić, Allison F. Vitonis, et al.. (2021). Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk. Cancer Prevention Research. 14(8). 795–802. 5 indexed citations
5.
Cramer, Daniel W., William J. Benjamin, Allison F. Vitonis, et al.. (2020). Differential blood count as triage tool in evaluation of pelvic masses. International Journal of Gynecological Cancer. 31(5). 733–743. 3 indexed citations
6.
Elias, Kevin M., Wojciech Fendler, Konrad Stawiski, et al.. (2017). Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. eLife. 6. 107 indexed citations
7.
Anderson, Karen S., Jessica Wong, Allison F. Vitonis, et al.. (2010). p53 Autoantibodies as Potential Detection and Prognostic Biomarkers in Serous Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 19(3). 859–868. 85 indexed citations
8.
Zhang, Lifang, Dan Wang, Dale Edwards, et al.. (2010). Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium. Reproductive Biology and Endocrinology. 8(1). 74–74. 20 indexed citations
9.
Meeker, John D., Stacey A. Missmer, Larisa Altshul, et al.. (2009). Serum and follicular fluid organochlorine concentrations among women undergoing assisted reproduction technologies. Environmental Health. 8(1). 32–32. 44 indexed citations
10.
Estes, Stephanie J., Bin Ye, Weiliang Qiu, et al.. (2008). A proteomic analysis of IVF follicular fluid in women ≤32 years old. Fertility and Sterility. 92(5). 1569–1578. 65 indexed citations
11.
Aponte, Margarita, Joseph Kwong, Samuel C. Mok, et al.. (2006). Gingkolide may prevent ovarian cancer through the platelet activating factor receptor (PAFR) pathway.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations
12.
Meeker, John D., Stacey A. Missmer, Daniel W. Cramer, & Russ Hauser. (2006). Maternal exposure to second-hand tobacco smoke and pregnancy outcome among couples undergoing assisted reproduction. Human Reproduction. 22(2). 337–345. 37 indexed citations
13.
Terry, Kathryn L., Immaculata De Vivo, Linda Titus‐Ernstoff, Mei‐Chiung Shih, & Daniel W. Cramer. (2005). Androgen Receptor Cytosine, Adenine, Guanine Repeats, and Haplotypes in Relation to Ovarian Cancer Risk. Cancer Research. 65(13). 5974–5981. 43 indexed citations
14.
Cramer, Daniel W., Mark D. Hornstein, Patricia M. McShane, et al.. (2003). Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization. American Journal of Obstetrics and Gynecology. 189(4). 1085–1092. 29 indexed citations
15.
Kuohung, Wendy, Georgina Jones, Allison F. Vitonis, et al.. (2002). Characteristics of patients with endometriosis in the United States and the United Kingdom. Fertility and Sterility. 78(4). 767–772. 44 indexed citations
16.
Harlow, Bernard L., Fredric D. Frigoletto, Daniel W. Cramer, et al.. (1996). Determinants of preterm delivery in low-risk pregnancies. Journal of Clinical Epidemiology. 49(4). 441–448. 64 indexed citations
17.
Beral, Valerie, Robert T. Rolfs, M R Joesoef, Sevgi O. Aral, & Daniel W. Cramer. (1994). Primary infertility: characteristics of women in North America according to pathological findings.. Journal of Epidemiology & Community Health. 48(6). 576–579. 8 indexed citations
18.
Harlow, Bernard L., et al.. (1991). The Influence of Lactose Consumption on the Association of Oral Contraceptive Use and Ovarian Cancer Risk. American Journal of Epidemiology. 134(5). 445–453. 19 indexed citations
19.
Cramer, Daniel W., Isaac Schiff, Stephen C. Schoenbaum, et al.. (1985). Tubal Infertility and the Intrauterine Device. Obstetrical & Gynecological Survey. 40(9). 596–597. 20 indexed citations
20.
Cramer, Daniel W., Alexander M. Walker, & Isaac Schiff. (1979). Statistical methods in evaluating the outcome of infertility therapy. Fertility and Sterility. 32(1). 80–86. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026